PPC
EW icon

Park Place Capital’s Edwards Lifesciences EW Stock Holding History

Park Place Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6K Buy
172
+80
+87% +$6.7K ﹤0.01% 752
2026
Q1 		$7.37K Sell
92
-5
-5% -$412 ﹤0.01% 639
2025
Q4 		$8.27K Hold
97
– – ﹤0.01% 601
2025
Q3 		$7.54K Buy
97
+31
+47% +$2.42K ﹤0.01% 600
2025
Q2 		$5.09K Hold
66
– – ﹤0.01% 658
2025
Q1 		$4.78K Sell
66
-2
-3% -$143 ﹤0.01% 669
2024
Q4 		$5.03K Sell
68
-30
-31% -$2.1K ﹤0.01% 669
2024
Q3 		$6.47K Sell
98
-181
-65% -$13.2K ﹤0.01% 681
2024
Q2 		$25.8K Sell
279
-1,085
-80% -$96.1K 0.01% 458
2024
Q1 		$130K Sell
1,364
-1,353
-50% -$114K 0.05% 285
2023
Q4 		$207K Sell
2,717
-1,222
-31% -$85K 0.08% 216
2023
Q3 		$273K Sell
3,939
-120
-3% -$9.64K 0.08% 200
2023
Q2 		$383K Sell
4,059
-745
-16% -$64.8K 0.11% 171
2023
Q1 		$397K Sell
4,804
-470
-9% -$36.9K 0.11% 171
2022
Q4 		$393K Buy
+5,274
New +$406K 0.11% 171

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Park Place Capital's EW Position: Q2 2026 in Review

Park Place Capital increased its Edwards Lifesciences (EW) stake by 87% in Q2 2026, buying an estimated $6.7K and bringing the position to 172 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Park Place Capital first reported a position in EW in Q4 2022 and has held it in 15 quarters since. The position peaked at $397K in Q1 2023. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Park Place Capital held 172 shares of Edwards Lifesciences worth $15.6K as of Q2 2026.
  • Park Place Capital bought 80 Edwards Lifesciences shares in Q2 2026, an estimated $6.7K.
  • Edwards Lifesciences made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #752 holding.
  • Park Place Capital first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Edwards Lifesciences position peaked at $397K in Q1 2023.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.